Enoxaparin vs Unfractionated Heparin in High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Intended Early Invasive Strategy

Authors:
  • JFJames J Ferguson
    James J Ferguson
  • RCRobert M Califf
    Robert M Califf
  • EAElliott M Antman
    Elliott M Antman
  • MCMarc Cohen
    Marc Cohen
  • CGCindy L Grines
    Cindy L Grines
  • SGShaun Goodman
    Shaun Goodman
  • DKDean J Kereiakes
    Dean J Kereiakes
  • ALAnatoly Langer
    Anatoly Langer
  • KMKenneth W Mahaffey
    Kenneth W Mahaffey
  • CNChristopher C Nessel
    Christopher C Nessel
  • PAPaul W Armstrong
    Paul W Armstrong
  • AAAlvaro Avezum
    Alvaro Avezum

Abstract
Medical therapies for non–ST-segment elevation acute coronary syndromes (ACS) have evolved dramatically over the last decade.1,2 At the same time, trials in high-risk patients have confirmed the benefit of an early invasive treatment strategy with diagnostic angiography and subsequent revascularization, compared with a conservative approach.3,4

This publication has 9 references indexed in Scilit: